Keros Therapeutics Inc (KROS) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Keros Therapeutics Inc   (NASDAQ: KROS)


Keros Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Keros Therapeutics Inc's ROI in the second quarter of 2026?
Keros Therapeutics Inc recorded a cumulative net loss of $-83 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -20.65%.

Within the Healthcare sector 315 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3098 to 3260.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -38.26 % -11.06 % 22.92 % 54.6 % 67.7 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 275 299 318 719 726
Return On Investment (TTM) -20.65 % -16.52 % 13.88 % 9.28 % 2.88 %
KROS's Overall Ranking # 3260 # 3098 # 325 # 979 #
Seq. Investment Change TTM -21.84 % -17.78 % -9.75 % 6.45 % 12.59 %
Seq. Net Income Change TTM - - 35.01 % 243.31 % 345.7 %
Net Income (TTM) in Millions -83 -85 87 64 19

KROS Company Profile >> Back to KROS Roi Comparisons >> See Annual KROS Return On Investment



Return On Investment KROS's Ranking
Within: No.
Industry # 113
Sector # 316
Overall # 3260

Return On Investment Statistics
High Average Low
13.88 %
-29.88 %
-98.14 %
(Dec 31 2025)   (Mar 31 2020)







Financial Statements
Keros Therapeutics Inc's II. Quarter Investments $ 275 Millions KROS's Balance sheet
Keros Therapeutics Inc's II. Quarter Income $ -29 Millions Quarterly KROS's Income Statement
KROS's Income by Division See KROS's Income by Division


KROS Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 318 588 346 290 243
Y / Y Investment Growth -46.03 % 70.24 % 19.09 % 19.24 % -7.19 %
Net Income in Millions 87 -187 -153 -105 -59
Y / Y Net Income Growth - - - - -
Annual Return On Investment 27.4 % -31.84 % -44.26 % -36.07 % -24.13 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 27.4 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
KROS's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for KROS's Competitors
Subscribers only: Roi for Keros Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for KROS's Customers

Other Ratios
KROS's Roa KROS's Inventory Turnover Ratio KROS's Growth Rates KROS's Dividend Statistics
KROS's Profitability Ratios KROS's Asset Turnover Ratio KROS's Dividend Growth
KROS's Roe KROS's Valuation Ratios KROS's Financial Strength Ratios KROS's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-12T18:37:40+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.